Company Filing History:
Years Active: 2023-2025
Title: Simchon Faigler: Innovator in Nucleic Acid Detection
Introduction
Simchon Faigler is a notable inventor based in Bet Izhak, Israel. He has made significant contributions to the field of genetic research, particularly in the detection of nucleic acid variants. With a total of 2 patents to his name, Faigler's work is paving the way for advancements in genetic testing and analysis.
Latest Patents
Faigler's latest patents focus on methods for detecting nucleic acid variants. These methods describe how to detect a short genetic variant in a test sample. In some exemplary methods, the short genetic variant is identified using one or more match scores. These scores are determined using sequencing data sets obtained from a test nucleic acid molecule. The test sequencing data sets are generated by sequencing the test nucleic acid molecule with non-terminating nucleotides provided in separate nucleotide flows according to a flow-cycle order. Additionally, the patents describe methods of sequencing a test nucleic acid molecule using two or more different flow-cycle orders and/or extended flow cycle orders that include five or more nucleotide flows per flow cycle.
Career Highlights
Simchon Faigler is currently associated with Ultima Genomics, Inc., where he continues to innovate in the field of genetic research. His work is instrumental in developing new techniques that enhance the accuracy and efficiency of genetic testing.
Collaborations
Faigler has collaborated with notable colleagues such as Gilad Almogy and Mark Pratt. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Simchon Faigler's contributions to the field of nucleic acid detection are significant and impactful. His innovative methods are set to enhance genetic testing and pave the way for future advancements in the field.